Title : Idebenone-Activating Autophagic Degradation of α-Synuclein via Inhibition of AKT-mTOR Pathway in a SH-SY5Y-A53T Model of Parkinson's Disease: A Network Pharmacological Approach.

Pub. Date : 2021

PMID : 34567221






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Idebenone-Activating Autophagic Degradation of alpha-Synuclein via Inhibition of AKT-mTOR Pathway in a SH-SY5Y-A53T Model of Parkinson"s Disease: A Network Pharmacological Approach. idebenone synuclein alpha Homo sapiens
2 In the cell model of PD, Idebenone activated autophagy and promoted alpha-synuclein degradation by suppressing the AKT/mTOR pathway. idebenone synuclein alpha Homo sapiens
3 Pretreating cells with chloroquine (CQ) to block autophagic flux could diminish the pharmacological effect of Idebenone to clear alpha-synuclein. idebenone synuclein alpha Homo sapiens
4 Conclusion: This study demonstrated that Idebenone exerts its anti-PD effects by enhancing autophagy and clearance of alpha-synuclein, thus providing a theoretical and experimental basis for Idebenone therapy against PD. idebenone synuclein alpha Homo sapiens
5 Conclusion: This study demonstrated that Idebenone exerts its anti-PD effects by enhancing autophagy and clearance of alpha-synuclein, thus providing a theoretical and experimental basis for Idebenone therapy against PD. idebenone synuclein alpha Homo sapiens